Early regulatory strategy in product development minimizes costly rework, accelerates market entry, and controls costs by aligning FDA/Health Canada requirements,…
This guide outlines how product classification, intended use, and risk determine FDA and Health Canada regulatory pathways. It emphasizes accurate…
Product launches risk delays or rejection by assuming compliance is a last-minute checklist. Avoid this by understanding regulations, planning realistic…
The article details how drug manufacturers must go beyond consumer tools like WebMD's Pill Identifier by using pill imprints, NDCs,…
A robust QMS ensures regulatory submission success and ongoing compliance by aligning with GMP, ISO 13485, risk management, data integrity,…
Align labeling, claims, and evidence per FDA and Health Canada rules to avoid delays and enforcement. Use substantiation matrices, clinical…
Conduct a thorough regulatory gap analysis addressing US FDA and Health Canada requirements, labeling, claims substantiation, risk management (ISO 14971),…
This guide details the complex Canadian NPN licensing process, covering product classification, evidence requirements, timelines, GMP compliance, and labeling. Arora…
This guide clarifies US FDA and Health Canada regulatory pathways for pharma, devices, NHPs, and cosmetics to ensure correct classification,…
This guide details Health Canada's Natural Health Product regulations, covering NPN licensing, site compliance, and labeling. Arora 297 Consultancy offers…
Call Now Button